our brain tumor cocktails and stories
Pages
Home
User Information
Brain Tumor Library
Drug Interactions
Drug Dosing
Toxicities
Drug and Supplement sources
Handy links
Wednesday 29 November 2017
Orphan Drug Status for BXQ-350
FDA granted Bexion Orphan Drug status for Saposin C, the active ingredient in its proprietary drug BXQ-350, for the potential treatment of glioblastoma.
http://bit.ly/2AlVuGb
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment